Need professional-grade analysis? Visit stockanalysis.com
$891.05M
N/A
N/A
N/A
Fortrea Holdings Inc. (FTRE) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $10.50, up 1.74% from the previous close.
Over the past year, FTRE has traded between a low of $4.06 and a high of $18.40. The stock has gained 79.2% over this period. It is currently 42.9% below its 52-week high.
Fortrea Holdings Inc. has a market capitalization of $891.05M.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Side-by-side comparison against top Healthcare peers.